{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-384527","form_type":"8-K","ticker":"ASPI","cik":"0001921865","company_name":"ASP Isotopes Inc.","filed_at":"2026-09-08T13:20:20+00:00","discovered_at":"2026-09-08T13:21:01.248802+00:00","generated_at":"2026-09-08T13:21:06.432877+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"ASP Isotopes hosts Capital Markets Day, targets $300M EBITDA by 2031","bullets":["CEO Paul Mann: 2026 is transition from building to producing; expects first commercial shipments from stable isotope division within 12 months.","Targets >$300 million EBITDA in 2031; expects revenue growth from liquid helium (Phase 1 completion) and radiopharmacy growth.","Pursuing public listings of Quantum Leap Energy and Noble Africa as separate public companies.","Inaugural Capital Markets Day held in London on Sept 8, 2026; presentation available on IR site."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-384527","json":"https://secwatch.observer/filing/0001193125-26-384527.json","markdown":"https://secwatch.observer/filing/0001193125-26-384527.md","text":"https://secwatch.observer/filing/0001193125-26-384527.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1921865/000119312526384527/0001193125-26-384527-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1921865/000119312526384527/aspi-20260908.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-08T13:21:06.432877+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}